SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-23-011251
Filing Date
2023-04-27
Accepted
2023-04-27 08:23:21
Documents
14
Period of Report
2023-03-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A gnpx20230407_8ka.htm   iXBRL 8-K/A 32445
2 EXHIBIT 16.1 ex_498357.htm EX-16.1 3038
  Complete submission text file 0001437749-23-011251.txt   181175

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20230303.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20230303_def.xml EX-101.DEF 12676
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20230303_lab.xml EX-101.LAB 17024
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20230303_pre.xml EX-101.PRE 12997
8 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20230407_8ka_htm.xml XML 2856
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38244 | Film No.: 23852083
SIC: 2834 Pharmaceutical Preparations